EMBION Technologies S.A. is a hard-tech disruptor, providing access to next-generation nutrition innovation through its proprietary platform technology. The spin-off of the Swiss Federal Institute of Technology in Lausanne (EPFL) specializes in the novel extraction and formulation of high- performance plant-based bioactives for human nutrition, personal care, and animal feed. The novel technology approach accelerates the development of higher functional nutrition, while significantly reducing cost and time-to-market. With this invention, EMBION catalyzes the future of nutrition toward a circular bioeconomy.
EMBION is based on a technology invention funded by Swiss National Science Foundation (SNSF- NRP66). To date, EMBION has secured public and seed funding from private investors. The company has grown from the founding team to an international team of chemical engineers, chemists, food technologists, and business experts.